Journey Medical (DERM) Net Equity Issued and Repurchased (2021 - 2025)
Journey Medical (DERM) posted Net Equity Issued and Repurchased of $5.4 million for Q4 2025, down 21.35% on a QoQ basis from $6.9 million in Q3 2025, and down 12.57% year-over-year from $6.2 million in Q4 2024.
Journey Medical (DERM) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Journey Medical's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $5.4 million for Q4 2025.
- Quarterly Net Equity Issued and Repurchased fell 12.57% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.4 million (up 107.68% YoY) and the FY2025 annual result came in at $16.4 million, up 107.68% from the prior year.
- Net Equity Issued and Repurchased was $5.4 million for Q4 2025 at Journey Medical, down from $6.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $12.5 million in Q1 2021 and bottomed at $194000.0 in Q3 2024.
- A 3-year average of $4.8 million and a median of $4.6 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 3452.06% in 2025, while the deepest fall reached 12.57% in 2025.
- Journey Medical's Net Equity Issued and Repurchased stood at $4.6 million in 2021, then soared by 33.74% to $6.2 million in 2024, then fell by 12.57% to $5.4 million in 2025.
- Business Quant data shows DERM's Net Equity Issued and Repurchased at $5.4 million in Q4 2025, $6.9 million in Q3 2025, and $4.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.42 Mn |
| Dec 31, 2025 | 5.42 Mn |
| Sep 30, 2025 | 6.89 Mn |
| Sep 30, 2025 | 6.89 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 194,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Sep 30, 2021 | 4.64 Mn |
| Sep 30, 2021 | 4.64 Mn |
| Jun 30, 2021 | 1.80 Mn |
| Jun 30, 2021 | 1.80 Mn |
| Mar 31, 2021 | 12.54 Mn |
| Mar 31, 2021 | 12.54 Mn |